Oh, H. Et Al. 2022. Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress. Biochemical Pharmacology , vol.203 .

Oh, H., Cho, W., HASSIBELNABY, A. M. A., Bayram, C., Jeong, J. H., & Jung, T. W., (2022). Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress. Biochemical Pharmacology , vol.203.

Oh, Heeseung Et Al. "Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress," Biochemical Pharmacology , vol.203, 2022

Oh, Heeseung Et Al. "Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress." Biochemical Pharmacology , vol.203, 2022

Oh, H. Et Al. (2022) . "Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress." Biochemical Pharmacology , vol.203.

@article{article, author={Heeseung Oh Et Al. }, title={Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress}, journal={Biochemical Pharmacology}, year=2022}